30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Chris Scott

Insider profile

Currently holds a position at IRadimed Corp

Performance

Overall performance
2.9

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 32% 68% 82%
Transactions
8 12% Buy
34 71% Buy
47 69% Buy

Performance for realised trades
4.4
Average return 220%
Success rate 73%
Average holding period 220
Transactions 28

Positions

Position Company Period
Chief Financial Officer, Corporate Secretary IRadimed Corp Dec. 1, 2013 -

Chris Scott's trades of IRadimed Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-02-11 2022-02-11 S Sale
11,683 -49.1%
55.70
US$1,741,602
11,683 -49.1% 55.70 US$1,741,602
2021-11-24 2021-11-23 S Sale
71,628 -23.1%
124.61
US$232,997
71,628 -23.1% 124.61 US$232,997
2021-11-17 2021-11-17 S Sale
60,274 -31.4%
455.88
US$526,222
60,274 -31.4% 455.88 US$526,222
2021-11-17 2021-11-16 S Sale
4,255 -13.0%
40.00
US$170,200
4,255 -13.0% 40.00 US$170,200
2021-11-17 2021-11-15 S Sale
2,027 -6.6%
40.10
US$81,279
2,027 -6.6% 40.10 US$81,279
2020-11-24 2020-11-24 S Sale
30,000
7.30
£219,000
30,000 7.30 £219,000
2020-11-24 2020-11-24 S Sale
30,000
7.30
£219,000
30,000 7.30 £219,000
2019-01-07 2019-01-07 B Purchase
4,400
2.28
£10,032
4,400 2.28 £10,032